Evidence map›Paper›PMID 32777940›Full record

ArticleAIDS research and human retroviruses2020

A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.

Scott Sherrill-Mix, Kaleigh Connors, Grace M Aldrovandi, Jason M Brenchley, Charles Boucher, Frederic D Bushman, Ronald G Collman, Satya Dandekar, Nichole R Klatt, Laurel A Lagenaur and 5 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS research and human retroviruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 4 countries.

Scott Sherrill-MixDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kaleigh ConnorsDepartment of Epidemiology, The George Washington University, Washington, District of Columbia, USA.
Grace M AldrovandiDepartment of Pediatrics, University of California, Los Angeles, Los Angeles, California, USA.
Jason M BrenchleyLaboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA.
Charles BoucherDepartment of Virosciences, Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, the Netherlands.
Frederic D BushmanDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ronald G CollmanDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Satya DandekarDepartment of Medical Microbiology and Immunology, University of California, Davis, Davis, California, USA.
Nichole R KlattDepartment of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Laurel A LagenaurOsel, Inc., Mountain View, California, USA.
Roger ParedesInstitut de Recerca de la SIDA IrsiCaixa i Unitat VIH, Universitat Autònoma de Barcelona, Universitat de Vic, Vic, Spain.
Gilda TachedjianBurnet Institute, Melbourne, Australia.
Jim A TurpinDivison of AIDS, NIAID, NIH, Bethesda, Maryland, USA.
Alan L LandayDivision of Gerontology, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Mimi GhoshDepartment of Epidemiology, The George Washington University, Washington, District of Columbia, USA.
University of Pennsylvania · USGeorge Washington University · USBurnet Institute · AUErasmus MC · NLNational Institutes of Health · USOffice of AIDS Research · USOsel (United States) · USRush University Medical Center · USUniversitat de Vic - Universitat Central de Catalunya · ESUniversity of California, Davis · USUniversity of California, Los Angeles · USUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In October of 2019, researchers and community members from around the world met at the NIH for the fifth annual International Workshop on Microbiome in HIV. New research was presented on the role of the microbiome on chronic inflammation and vaccine design, interactions of genetics, environment, sexual practice and HIV infection with the microbiome and the development and clinical trials of microbiome-based therapeutic approaches intended to decrease the probability of HIV acquisition/transmission or ameliorate sequelae of HIV. The keynote address by Dr. Jacques Ravel focused on his work on the vaginal microbiome and efforts to improve the analysis and resolution of microbiome data.

Indexed as

Biomedical ResearchHIV InfectionsMicrobiotaEducational StatusFemaleHumansVaginacomorbiditiesHIV/SIVmicrobiomepathogenesistherapeuticstransmission

Identifiers

PMID32777940
PMCPMC7869876
OpenAlexW2999521122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.